Odidi Holdings Inc., through its subsidiary, IntelliPharmaCeutics International Inc., engages in the research, development, licensing, and marketing of new and generic controlled release pharmaceutical products. Odidi Holdings Inc. was formerly known as IntelliPharmaCeutics Inc. The company was founded in 1998 and is based in Toronto, Canada.
Dr. Isa Odidi Chairman of the Board and Chief Executive Officer
Isa Odidi belongs to Nigerian royalty, holding the title of Sardaun. Yet in a bid to see the Western world while garnering higher education in pharmaceutics, he left behind the stately life and went to the United Kingdom along with his wife, Amina. A few years later, in 1995, they came to Canada as research doctors with their children.
Isa was here on a two-year contract to help Canada’s largest pharmaceutical firm Biovail Corporation set up its R&D department. “It wasn’t our intention to come and live in Canada,” remembers Isa. “It was supposed to be for only two years. But then the company became so successful with our presence — we made a lot of products for them and stock price went high and everyone became rich, so to speak — so two years became extended for more years.”
Meanwhile, the Odidis fell in love with the country and decided to settle here permanently. The couple has flourished ever since, finding personal success and integrating into Canadian society.
News 
Market Data 
Discover 
AI
